PRESS-RELEASE ·Filed Apr 22, 2026
Press release · Earnings
Final — all horizons settled through T+60d
LFVN ▲ +26.21% at T+60d
NEUTRAL call +26.21% · α vs SPY +21.19% · entry $4.96 → $6.26
T+1d
+2.42%
call +2.42% · α +1.63%
$5.08
settled 6mo ago
T+5d
+1.81%
call +1.81% · α +0.34%
$5.05
settled 6mo ago
T+20d
+5.85%
call +5.85% · α +1.21%
$5.25
settled 5mo ago
T+60d
+26.21%
call +26.21% · α +21.19%
$6.26
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
LifeVantage Corporation announced it will report its fiscal Q3 2026 results on May 6, 2026.
Key Facts
- LifeVantage Corporation announced it will report its fiscal Q3 2026 results on May 6, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3279378 |
5 reports for LFVN
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | SC 13G/A | $5.86 | awaiting T+20 | — | $5.93 (+1.19%) |
Aug 27, 2026 8w ago | Press Release | $6.36 $6.19 | ▲ +2.60% | ▲ +2.86% | $5.93 (+6.69%) |
Aug 21, 2026 9w ago | Press Release | $6.69 $6.22 | ▼ −7.03% | ▼ −6.50% | $5.93 (−11.36%) |
Apr 22, 2026 26w ago | Press Release | $4.96 $5.25 | ▲ +5.85% | ▲ +1.21% | $5.93 (+19.56%) |
Mar 23, 2026 31w ago | EFFECT | $4.54 $4.91 | ▲ +8.15% | ▲ +0.73% | $5.93 (+30.62%) |
Showing 5 of 5
US Market Status
Market Closed — Opens Thu (11h 28m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers